This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Nomegestrol acetate
Accession Number
DB13981
Type
Small Molecule
Groups
Investigational
Description

Nomegestrol acetate, also known as NOMAC, is a progestin used in oral contraceptives, menopausal hormone therapy, and for the treatment of gynecological disorders.

Structure
Thumb
Synonyms
  • 17-alpha-Acetoxy-6-methyl-19-nor-4,6-pregnadiene-3,20-dione
  • 17-alpha-Hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione acetate
External IDs
ORG 10486-0 / ORG-10486-0 / TX 066 / TX-066
Categories
UNII
83J78V5W05
CAS number
58652-20-3
Weight
Average: 370.489
Monoisotopic: 370.214409446
Chemical Formula
C23H30O4
InChI Key
IIVBFTNIGYRNQY-YQLZSBIMSA-N
InChI
InChI=1S/C23H30O4/c1-13-11-20-18(17-6-5-16(26)12-19(13)17)7-9-22(4)21(20)8-10-23(22,14(2)24)27-15(3)25/h11-12,17-18,20-21H,5-10H2,1-4H3/t17-,18-,20-,21+,22+,23+/m1/s1
IUPAC Name
(1R,3aS,3bS,9aR,9bS,11aS)-1-acetyl-5,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate
SMILES
[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C(C)=C[C@@]21[H]

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
(R)-warfarinNomegestrol acetate may decrease the anticoagulant activities of (R)-warfarin.
(S)-WarfarinNomegestrol acetate may decrease the anticoagulant activities of (S)-Warfarin.
4-hydroxycoumarinThe therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Nomegestrol acetate.
4-OxoretinolThe therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with 4-Oxoretinol.
7-NitroindazoleThe metabolism of Nomegestrol acetate can be increased when combined with 7-Nitroindazole.
AbciximabNomegestrol acetate may decrease the anticoagulant activities of Abciximab.
AcenocoumarolThe therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Nomegestrol acetate.
AcetaminophenThe metabolism of Nomegestrol acetate can be increased when combined with Acetaminophen.
AcetazolamideThe metabolism of Nomegestrol acetate can be increased when combined with Acetazolamide.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be decreased when used in combination with Nomegestrol acetate.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
KEGG Drug
D08281
ChemSpider
82771
ChEBI
135564
ChEMBL
CHEMBL1476022
Wikipedia
Nomegestrol_acetate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedNot AvailableContraception1
1CompletedNot AvailableHealthy Volunteers1
1WithdrawnBasic ScienceBioequivalence1
2CompletedTreatmentContraception1
2CompletedTreatmentDysmenorrhea1
3CompletedPreventionContraception1
3TerminatedPreventionContraception1
3Unknown StatusTreatmentDisseminated Sclerosis1
3WithdrawnTreatmentContraception1
4TerminatedScreeningContraception / Hypercoagulability1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00415 mg/mLALOGPS
logP3.46ALOGPS
logP3.42ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)17.72ChemAxon
pKa (Strongest Basic)-4.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area60.44 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity104.18 m3·mol-1ChemAxon
Polarizability41.78 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Enzymes

Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Vitamin d3 25-hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation react...
Gene Name
CYP3A4
Uniprot ID
P08684
Uniprot Name
Cytochrome P450 3A4
Molecular Weight
57342.67 Da
References
  1. Binkowska M, Woron J: Progestogens in menopausal hormone therapy. Prz Menopauzalny. 2015 Jun;14(2):134-43. doi: 10.5114/pm.2015.52154. Epub 2015 Jun 22. [PubMed:26327902]

Drug created on January 20, 2018 08:25 / Updated on November 02, 2019 03:19